Isofol Medical AB

Research Isofol Medical AB (ISOFOL) on Bullrun: market cap SEK 231.39M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerISOFOL
• ExchangeST
• CountrySweden
• SectorHealthcare
• IndustryBiotechnology
• CurrencySEK
• Market capSEK 231.39M
• Financial periodFY2022
• RevenueSEK 12.80M
• Revenue growth-42.9%
• Net income-SEK 159.76M
• Free cash flow-SEK 190.98M

Valuation Snapshot

latest market cap is SEK 231.39M.

About Isofol Medical AB

Isofol Medical AB (publ) operates as a clinical stage biotech company. It develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. The company was incorporated in 2008 and is based in Gothenburg, Sweden.

Frequently asked questions

What is Isofol Medical AB's market cap?

Isofol Medical AB's market capitalization is SEK 231.39M.

What does Isofol Medical AB do?

Isofol Medical AB (publ) operates as a clinical stage biotech company. It develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. The company was incorporated in 2008 and is based in Gothenburg, Sweden.